Literature DB >> 19201184

Impact of South American heroin on the US heroin market 1993-2004.

Daniel Ciccarone1, George J Unick, Allison Kraus.   

Abstract

BACKGROUND: The past two decades have seen an increase in heroin-related morbidity and mortality in the United States. We report on trends in US heroin retail price and purity, including the effect of entry of Colombian-sourced heroin on the US heroin market.
METHODS: The average standardized price ($/mg-pure) and purity (% by weight) of heroin from 1993 to 2004 was from obtained from US Drug Enforcement Agency retail purchase data for 20 metropolitan statistical areas. Univariate statistics, robust Ordinary Least Squares regression and mixed fixed and random effect growth curve models were used to predict the price and purity data in each metropolitan statistical area over time.
RESULTS: Over the 12 study years, heroin price decreased 62%. The median percentage of all heroin samples that are of South American origin increased an absolute 7% per year. Multivariate models suggest percent South American heroin is a significant predictor of lower heroin price and higher purity adjusting for time and demographics.
CONCLUSION: These analyses reveal trends to historically low-cost heroin in many US cities. These changes correspond to the entrance into and rapid domination of the US heroin market by Colombian-sourced heroin. The implications of these changes are discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19201184      PMCID: PMC2719678          DOI: 10.1016/j.drugpo.2008.12.001

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  32 in total

1.  High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco.

Authors:  I A Binswanger; A H Kral; R N Bluthenthal; D J Rybold; B R Edlin
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

2.  Drug prices and emergency department mentions for cocaine and heroin.

Authors:  J P Caulkins
Journal:  Am J Public Health       Date:  2001-09       Impact factor: 9.308

Review 3.  Evaluating explanations of the Australian 'heroin shortage'.

Authors:  Louisa Degenhardt; Peter Reuter; Linette Collins; Wayne Hall
Journal:  Addiction       Date:  2005-04       Impact factor: 6.526

4.  Care of injection drug users with soft tissue infections in San Francisco, California.

Authors:  Hobart W Harris; David M Young
Journal:  Arch Surg       Date:  2002-11

5.  Wound botulism in California, 1951-1998: recent epidemic in heroin injectors.

Authors:  S B Werner; D Passaro; J McGee; R Schechter; D J Vugia
Journal:  Clin Infect Dis       Date:  2000-10-25       Impact factor: 9.079

6.  Unintentional opiate overdose deaths--King County, Washington, 1990-1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2000-07-21       Impact factor: 17.586

7.  Heroin use in New South Wales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the Illicit Drug Reporting System (IDRS).

Authors:  Shane Darke; Ibby Topp; Harlene Kaye; Wayne Hall
Journal:  Addiction       Date:  2002-02       Impact factor: 6.526

8.  An overview of heroin trends in New York City: past, present and future.

Authors:  B Frank
Journal:  Mt Sinai J Med       Date:  2000 Oct-Nov

9.  Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study.

Authors:  E L Murphy; D DeVita; H Liu; E Vittinghoff; P Leung; D H Ciccarone; B R Edlin
Journal:  Clin Infect Dis       Date:  2001-06-05       Impact factor: 9.079

10.  Supply control and harm reduction: lessons from the Australian heroin 'drought'.

Authors:  Don Weatherburn; Craig Jones; Karen Freeman; Toni Makkai
Journal:  Addiction       Date:  2003-01       Impact factor: 6.526

View more
  18 in total

1.  Illicit fentanyls in the opioid street market: desired or imposed?

Authors:  Sarah G Mars; Daniel Rosenblum; Daniel Ciccarone
Journal:  Addiction       Date:  2018-12-04       Impact factor: 6.526

2.  Fentanyl in the US heroin supply: A rapidly changing risk environment.

Authors:  Daniel Ciccarone
Journal:  Int J Drug Policy       Date:  2017-07-20

3.  Heroin uncertainties: Exploring users' perceptions of fentanyl-adulterated and -substituted 'heroin'.

Authors:  Daniel Ciccarone; Jeff Ondocsin; Sarah G Mars
Journal:  Int J Drug Policy       Date:  2017-07-18

4.  The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis.

Authors:  Daniel Ciccarone
Journal:  Int J Drug Policy       Date:  2019-02-02

5.  The effects of medical marijuana laws on potency.

Authors:  Eric L Sevigny; Rosalie Liccardo Pacula; Paul Heaton
Journal:  Int J Drug Policy       Date:  2014-01-18

6.  Urban segregation and the US heroin market: a quantitative model of anthropological hypotheses from an inner-city drug market.

Authors:  Daniel Rosenblum; Fernando Montero Castrillo; Philippe Bourgois; Sarah Mars; George Karandinos; George Jay Unick; Daniel Ciccarone
Journal:  Int J Drug Policy       Date:  2013-12-18

7.  Nationwide increase in hospitalizations for heroin-related soft tissue infections: Associations with structural market conditions.

Authors:  Daniel Ciccarone; George Jay Unick; Jenny K Cohen; Sarah G Mars; Daniel Rosenblum
Journal:  Drug Alcohol Depend       Date:  2016-04-14       Impact factor: 4.492

8.  The entry of Colombian-sourced heroin into the US market: the relationship between competition, price, and purity.

Authors:  Daniel Rosenblum; George Jay Unick; Daniel Ciccarone
Journal:  Int J Drug Policy       Date:  2013-10-19

9.  The relationship between US heroin market dynamics and heroin-related overdose, 1992-2008.

Authors:  George Unick; Daniel Rosenblum; Sarah Mars; Daniel Ciccarone
Journal:  Addiction       Date:  2014-08-04       Impact factor: 6.526

10.  "Every 'never' I ever said came true": transitions from opioid pills to heroin injecting.

Authors:  Sarah G Mars; Philippe Bourgois; George Karandinos; Fernando Montero; Daniel Ciccarone
Journal:  Int J Drug Policy       Date:  2013-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.